Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Tetracycline and Erythromycin Resistant Mutants of the Mycoplasma pneumoniae Isolated from Patients with Respiratory Diseases

호흡기질환 환자로부터 분리된 Mycoplasma pneumoniae의 tetracycline과 erythromycin에 대한 저항성 변이

  • Chang Myung-Woong (Department of Microbiology, Kosin University College of Medcine) ;
  • Park In-Dal (Department of Microbiology, Kosin University College of Medcine) ;
  • Kim Kwang-Hyuk (Department of Microbiology, Kosin University College of Medcine) ;
  • Song Gap-Young (Department of Internal Medicine, Busan Adventist Hospital) ;
  • Kim Sung-Won (Department of Pediatrics, Busan St. Benedict Hospital)
  • 장명웅 (고신대학교 의과대학 미생물학교실) ;
  • 박인달 (고신대학교 의과대학 미생물학교실) ;
  • 김광혁 (고신대학교 의과대학 미생물학교실) ;
  • 송갑영 (부산 위생병원 내과) ;
  • 김성원 (부산 성분도병원 소아과)
  • Published : 2005.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

One hundred and twenty three strains of Mycoplasma pneumoniae were isolated from patients with respiratory diseases from February 2002 to April 2005 in Busan, Korea. The MICs of tetracycline and erythromycin up to $90\%$ of the 123 M. pneumoniae isolates tested were $0.5\~1.0$, and $0.5\~512{\mu}/ml$, respectively. Plasmid DNA was not isolated from all of the M. pneumoniae isolates. Out of 323 strains of M. pneumoniae, 57 ($46.3\%$) stains contain tetM gene on their chromosomal DNA, and 60 ($48.8\%$) strains were mutated in domain V of 23S rRNA for erythromycin resistance. Out of 63 strains of M. pneumoniae which were not mutated in domain V of 235 rRNA for erythromycin resistance, 36 ($57.1\%$) strains contained tetM gene, and out of 60 strains of M. pneumoniae which were mutated in domain V of 23S rRNA for erythromycin resistance, 21 ($35.0\%$) strains contained tetM gene. These results suggest that the isolation rate of erythromycin and tetracycline resistant M. pneumoniae is higher than those of other countries, and erythromycin and tetracycline are not first choice drug for M. pneumoniae infection in Korea, and it need confirm by a nationwide surveilance of antimicrobial resistance.

2002년 2월부터 2005년 4월까지 호흡기질환 환자로부터 분리된 M. pneumeniae 123 균주의 tetracycline과 erythromycin에 대한 MIC 범위는 각각 $0.5\~1.0$, and $0.5\~512{\mu}/ml$ 이었다. 분리된 M. pneumoniae 123 균주에서 plasmid DNA는 확인되지 않았다. 분리된 M. pneumoniae 123 균주 중에서 57($46.3\%$) 균주가 tetracycline에 저항성인 tetM유전자를 가지고 있었으며, 235 rRNA domain V에 erythromycin에 저항성 변이를 일으킨 균주가 60($48.8\%$)이었다. erythromycin에 저항성 변이를 일으키지 않은 63균주 중에서 tetM 유전자를 가지고 있는 균주는 36($57.1\%$)이었으며, erythromycin에 저항성 변이를 일으킨 60균주 중에서 21($35.0\%$ 균주가 tetM 유전자를 가지고 있었다. 본 연구로써 국내에서 tetracycline과 erythromycin에 대한 저항성 M. pneumoniae 균주의 분리율이 외국에 비하여 높으며, M. pneumoniae 감염의 치료에 erythromycin이 일차 선택제가 될 수 없으므로 이에 대한 범국가적 조사가 필요하다고 생각된다.

Keywords

References

  1. Aaij C., and P. Borst 1972. The gel electrophoresis of DNA. Biochem Biophys Acta. 269, 192-196 https://doi.org/10.1016/0005-2787(72)90426-1
  2. Arai S., Y. Gohara, K Kuwano, and T. Kawashima. 1992. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae. Antimicrob Agents Chemother. 36, 1322-1324 https://doi.org/10.1128/AAC.36.6.1322
  3. Barroso G., and J. Labarere. 1988. Chromosomal gene transfer in Spiroplasma citri. Sci. 242, 959-961
  4. Blanchard A, and C. Bebear. 2002. Mycoplasmas of human, pp 45-71, In Razin S, and Hermann R (ed), Molecular biology and pathogenicity .of mycoplasma. Kluwer Academic Pub., New York
  5. Braun P., J.O. Klein, and E.H. Kass. 1970. Susceptibility of genital mycoplasma to antimicrobial agents. Appl MicrobioI, 19, 62-65
  6. Brown J.T., and M.C. Roberts. 1987. Cloning and characterization of tetM gene from a Ureaplasma urealyticum strain. Antimicrob Agents Chemother, 31, 1852-1856 https://doi.org/10.1128/AAC.31.11.1852
  7. Burdett V. 1980. Identification of tetracycline resistant R plasmids in Streptococcus agalactiae (Group B). Antimicrob Agents Chemother. 18, 753-758 https://doi.org/10.1128/AAC.18.5.753
  8. Burdett V., J. Inamine, and S. Rajagopalan. 1986. Heterogeneity of tetracycline resistance determinants in Streptococcus. J Bacteriol. 165, 564-570
  9. Cassell G.H., W.A. Clyde, and J.K. Davis. 1985. Mycoplasmal respiratory infections. pp65-106, In The Mycoplasmas Vol. IV, Razin S and Barile MF (Ed), Academic Press, New York
  10. Chang MW., K.H. Kim, LD. Park, and M H Joh. 1995. Detection of Mycoplasma pneumoniae in clinical specimens of patients by polymerase chain reaction and culture method. J. Korean soc. Microbiol. 30, 517-525
  11. Chang M.W., K.H. Kim, I.D. Park, K.H. Kang, and E.H. Kong. 2003. Rapid detection of Mycoplasma pneumoniae and antimicrobial susceptibilities of the M. pneumoniae isolates. J Bacteriol Virol, 33, 183-191
  12. Chang M.W., K.H. Kim, I.D. Park, G.Y. Song, SW. Kim, E.Y. Lee, M.C. Kim, M.H. Cho, K.E. Kim, and C.E. Choi. 2005. Isolation of Mycoplasma pneumoniae and antimicrobial susceptibilities of the isolated (III). Korean J Life Sci, 15(3), 479-485 https://doi.org/10.5352/JLS.2005.15.3.479
  13. Clewell D.B., and C. Gawron-Burke. 1986. Conjugative transposon and the dissemination of antibiotic resistance in streptococci. Ann Rev Microbiol. 40:635-659 https://doi.org/10.1146/annurev.mi.40.100186.003223
  14. Cummings M.C., and W.M McCormack. 1990. Increase in resistance of Mycoplasma hominis to tetracycline. Antimicrob Agents chemother, 34, 2297-2300 https://doi.org/10.1128/AAC.34.12.2297
  15. Doutnwaite S, L.H. Hansen, and P. Mauvis. 2000. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol. Microbiol. 36, 183-192 https://doi.org/10.1046/j.1365-2958.2000.01841.x
  16. Dybvig K 1989. Transformation of Acholeplasma laidlawii with streptococcal plasmids pVA868 and pVA920. Plasmid, 21, 155-160 https://doi.org/10.1016/0147-619X(89)90061-9
  17. Ford O.K., and J.R Smith. 1974. Nonspecific urethritis associated with a tetracycline-resistant T-mycoplasama. Br J Vener Dis. 50, 373-377
  18. Furness G, and A.M. Cerone. 1979. Preparation of competent single-cell suspensions of M. hominis tetS and M. salivarium tetS for genetic transformation to tetracycline resistance by DNA extracted from M. hominis tet R. J Infect Dis, 139, 441-451
  19. Furneri P.M., G. Rappazzo, M.P. Musumarra, P. Dipietro, L.S. Catania, and L.S. Roccasalva. 2001. Two new point mutations at A2062 associated with resistance to 16-membered macrolode antibiotics in mutant strains of M. hominis. Antimicrob. Agents Chemother. 42, 2958-2960
  20. Hansen L.H., P. Mauvais, S. Douthwaite. 1999. The macrolide- ketolide antibiotic binding site is formed by structures in domain II and V of 23S ribosomal RNA. Mol. Microbiol. 31, 623-631 https://doi.org/10.1046/j.1365-2958.1999.01202.x
  21. Harasawa R, and MF. Barile. 1983. Survey of plasmids in various Mycoplasmas. Yale J BioI Med. 56, 783-789
  22. Hempstead P.G. 1990. An improved method for the rapid isolation of chromosomal DNA from Mycoplasma spp. Can J Microbiol 36, 59-64 https://doi.org/10.1139/m90-011
  23. Izumikawa K, Y. Hirakata, T. Yamaguchi, R. Yoshida, H. Tanaka, H. Takemura, S. Maesaki, K Tomono, M. Kaku, K Izumikawa, S. Kamihira, and S. Kohno. 1998. In vitro activities of quinupristin-Dalfopristin and the streptogramin RPRI06972 against M. pneumoniae. Antimicrob agents chemother. 42, 698-699
  24. Kaku M., K. Ishida, K. Irifune, R. Mizukane, H. Takemura, and R. Yoshida. 1994. In vitro activities of sparfloxacin against M. pneumoniae. Antimicrobil Agents Chemother. 38, 738-741 https://doi.org/10.1128/AAC.38.4.738
  25. Kang K.S., H.O. Woo. 2003. Pattern occurrence of Mycoplasma pneumoniae in admitted children: Southern central Korea, from 1989 to 2002. J Korean Pediatr Soc. 46, 474-479
  26. Kapusnik-Uner J.E., M.A. Sande, H.F. Chambers. 1996. Antimicrobial agents, tetracycline, chloramphenicol, erythromycin, and miscellaneous antimicrobial agents, pp1123-1153, In Goodman & Gilman,s The pharmacological basis of therapeutics, 9th(ed), McGraw-Hill, New York
  27. Kenny G.E., F.D. Cartwright. 1994. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to new glycycyclines in comparison with those to older tetracyclines. Antimicrob Agents Cjemother. 38, 2628-2632 https://doi.org/10.1128/AAC.38.11.2628
  28. Knapp J.S., S.R. Johson, J.M. Zenilman, M.C. Roberts, and S.A Morse. 1988. High-level tetracycline resistance due to tet M in strains of Neisseria species, Kingella detrificans, Eikenella corrodens. Antimicrob Agents Chemother, 32, 765-769 https://doi.org/10.1128/AAC.32.5.765
  29. Levey S.B. 1988. Tetracycline resistance determinants are wide spread. ASM News, 54, 418-422
  30. Levy S.B., L.M. McMurry, V. Burdett, P. Courvalin, W. Hillen, M.C. Roberts, and D.E. Taylor. 1989. Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother, 33, 1373-1378 https://doi.org/10.1128/AAC.33.8.1373
  31. Lucier T.S., K. Heitzman, S.K. Liu, and P.C. Hu. 1995. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of M. pneumoniae. Antimicrob. Agents Chemother. 39, 2770-2773 https://doi.org/10.1128/AAC.39.12.2770
  32. Mahairas G.G., C. Jian, and C. Minion. 1990. Genetic exchange of transposon and integrative plasmid markers in M. pulmonis. J Bacteriol, 172, 2267-2272
  33. Matsuoka M., M. Narita, N. Okazki, H. Ohya, and T. Yamazaki. 2004. Characterization and molecular analysis of macrolide-resistant M. pneumoniae clinical isolates obtained in Japan. Antimicrob. Agents Chemother. 48, 46244630
  34. Okazaki N., M. Narita, S. Yamada, K Izumikawa, M. Umetsu, T. Kenri, Y. Sasaki, Y. Arakawa, and T. Sasaki. 2001. Characteristics of macrolide-resistant M. pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol. lmmunol. 45, 617-620 https://doi.org/10.1111/j.1348-0421.2001.tb01293.x
  35. Park l.D.,. K.H. Kim, M.W. Chang, H.S. Park. 1992. Distribution of tetM gene in the tetracycline resistant Bacteria, J Korean Soc Microbiol. 27, 59-72
  36. Pereyre S., P. Gonzalez, B. de Barbeyrac, A Darnige, H. Renaudin, A Charron, S. Raherison, C.M. Bebear. 2002. Mutation in 23S rRNA account for intrinsic resistance to macrolides in M. hominis and M. fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob. Agents Chemother. 46, 3142-3150 https://doi.org/10.1128/AAC.46.10.3142-3150.2002
  37. Pereyre S., C Guyot, H. Renaudin, A Charron, C. Bebear, and C.M. Bebear. 2004. In vitro selection and characterization of resistance to macrolides and related antibiotics in M. pneumoniae. Antimicrob. Agents Chemother. 48, 460465
  38. Prunier A.L., B. Malbrunny, D. Tande, B. Picard, and R. Leclercq. 2002. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrb. Agents Chemother. 46, 3054-3065 https://doi.org/10.1128/AAC.46.9.3054-3056.2002
  39. Roberts M.C., L.A Koutsky, K.K Holmes, D.J. LeBlanc, and G.E. Kenny. 1985. Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrob agents Chemother, 28, 141-143 https://doi.org/10.1128/AAC.28.1.141
  40. Ross J.I., E.A. Eady, J.H. Cove, C.E. Jones, A.H. Ratyal, Y.W. Miller, S. Vyakranam, and W. Cunnliffe. 1997. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacterium isolated from acne patients is associated with mutation in 23S rRNA. Antimicrob Agents Chemother. 41, 1162-1165
  41. Schulunzen F., R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albercht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413, 814-821 https://doi.org/10.1038/35101544
  42. Suyama N., K. Ishida, M. Kaku, K. Izumikawa, and K. Hara. 1995. Therapeutic activites of macrolides against M. pneumoniae infection. Jap J Mycoplasmol. 21, 39-40
  43. Taylor-Robinson D. 1976. Mycoplasmas of various hosts and their antibiotic sensitivities. Prostgrand Med J Suppl, 43, 100-105
  44. Trzcinski K., B.S. Cooper, W. Hryniewicz, and C.G. Dowson. 2000. Expression of resistance to tetracycline in strains of methicllin-resistant Staphylococcus aureus. J Antimicrob Chemother. 45, 763-770 https://doi.org/10.1093/jac/45.6.763
  45. Vester B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitution in 23S rRNA. Antimicrob. Agents Chemother.45, 1-12 https://doi.org/10.1128/AAC.45.1.1-12.2001
  46. Waites K.B., L.B. Duffy, T. Schmid, D. Carb, M.S. Pate, and G.H. Cassell. 1991. In vitro susceptibilities of Mycoplasma pneumoniae, M. hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother. 35, 1181-1185 https://doi.org/10.1128/AAC.35.6.1181
  47. Weisblum B. 1995. Erythromycin resistance by ribosome modification. Antirnicrob. Agents Chemother. 39, 577-585 https://doi.org/10.1128/AAC.39.3.577

Cited by

  1. Multi-drug Resistance of Mycoplasma pneumoniae Isolates from Patients with Respiratory Diseases against Quinolone and Macrolide vol.17, pp.3, 2007, https://doi.org/10.5352/JLS.2007.17.3.435
  2. Detection of genetic mutations associated with macrolide resistance of Mycoplasma pneumoniae vol.53, pp.2, 2010, https://doi.org/10.3345/kjp.2010.53.2.178